Melina Rodriguez: First FDA-Approved VWD Prophylaxis for All Ages
Melina Rodriguez, Founder of Health Evidence Digest, Senior Medical Editor at Precision AQ, shared a post on LinkedIn:
“Von Willebrand Disease Is the Most Common Inherited Bleeding Disorder in the World. In Young Children With Severe Disease, Prophylactic Treatment Has Lacked Any FDA-Approved Option Until Now
On July 2, 2026, the FDA expanded Wilate (von Willebrand Factor/Coagulation Factor VIII Complex Human, Octapharma) approval to include routine prophylaxis in children younger than 6 years with von Willebrand disease, making it the first and only VWF concentrate approved for prophylaxis across all ages and all VWD types.
The Phase 3 WIL-33 trial (NCT04953884; n equals 12; median age 2.0 years; severe VWD) showed a mean total ABR of 4.6 (SD 6.1) during 12 months of prophylaxis; spontaneous ABR 0.9; 98.2% of all bleeds were minor; 95.6% of treated bleeds required only 1 infusion.
This was the first dedicated prospective clinical trial of VWF prophylaxis in children under 6 worldwide.
Here is what VWD is, why prophylaxis matters for young children with severe disease, and what the WIL-33 data shows across VWD types….”
Stay updated with Hemostasis Today.
-
Nov 3, 2026, 02:21Digambar Panchal: NGS Demonstrates Key Role in Solving Challenging Hematology Cases at LTMGH
-
Nov 3, 2026, 02:07David Smadja: Does Immediate Breast Reconstruction Increase the Risk of Thrombosis and Bleeding after a Mastectomy?
-
Nov 3, 2026, 01:57Nour Al-Mozain: What Does a Bathtub Have to Do with Hemoglobin S?
-
Nov 3, 2026, 01:51Cesar de Almeida Neto: Highlighting The Final Day of Hemo 2026
-
Nov 3, 2026, 01:34Jae Hyun Byun: Beyond Stenosis Understanding Carotid Plaque Instability
-
Nov 3, 2026, 01:20Smriti Yadav: A New Milestone in Transfusion Medicine
-
Nov 3, 2026, 00:55Dušan Ušjak: A Month of Research and Scientific Collaboration
-
Nov 3, 2026, 00:27Grace Gorecki: Early IVIG Accelerates Platelet Recovery in HIT
-
Nov 2, 2026, 22:15Micheline Mambue: A Case of Early Stent Thrombosis Successfully Managed With Repeat Angioplasty